B

Brown & Brown Insurance

Provides risk management and insurance solutions

Technology Risk & Compliance Analyst

Full-TimeUpdated on 10/4/2026
$85k - $105k/yr
Mid, Senior
Bachelor's
Texas, USA
RemoteTravel up to 30% is required.

About the job

Requirements
  • Bachelor’s degree in Information Technology, Cybersecurity, Business, or a related field.
  • 3–7 years of experience in IT risk, compliance, audit, or cybersecurity.
  • Strong working knowledge of governance, risk, and compliance frameworks such as NIST, ISO 27001, and COBIT.
  • Knowledge of regulatory standards such as SOX, SOC, GDPR, or similar standards.
  • Experience with risk assessment, control design, and audit support.
  • Ability to translate technical risk into business impact and executive-level messaging.
  • Strong collaboration and stakeholder management across technology and business teams.
  • High attention to detail and disciplined documentation practices.
  • Able to travel up to 30%.
Responsibilities
  • Identify, assess, and document technology risks across projects, products, and platforms within the Retail portfolio.
  • Facilitate prioritization of technology risks based on business impact, regulatory exposure, and defined risk appetite.
  • Conduct risk assessments for new initiatives, including mergers and acquisitions integrations and platform implementations.
  • Partner with project managers and product teams to integrate risk mitigation into delivery plans and milestones.
  • Ensure risk mitigation strategies align with enterprise risk appetite and portfolio priorities.
  • Monitor risk exposure and ensure remediation activities are tracked through completion.
  • Ensure alignment with internal policies and external regulatory requirements, including SOX, SOC controls, and data privacy standards.
  • Support implementation and maintenance of IT governance, risk, and compliance frameworks.
  • Evaluate technology policies, standards, and procedures for fitness and alignment with regulatory and business requirements.
  • Recommend updates to policies and standards based on regulatory changes, audit findings, and the evolving risk landscape.
  • Maintain compliance documentation, control narratives, and evidence repositories.
  • Monitor and report adherence to policies, standards, and standard operating procedures across the portfolio.
  • Support internal and external audit activities, including evidence collection, walkthroughs, and remediation tracking.
  • Partner with internal and external Audit to support audit outcomes, including SOX compliance, evidence validation, and timely remediation of findings.
  • Assess IT control effectiveness and identify gaps across applications, infrastructure, and processes.
  • Partner with control owners to strengthen control design and execution.
  • Drive timely closure of audit findings and control deficiencies.
  • Partner with Vendor Management and enterprise third- and fourth-party risk teams to identify and address technology-related vendor risks.
  • Incorporate vendor-related risks into portfolio-level risk visibility and reporting.
  • Support tracking and remediation of vendor-related control gaps impacting Retail Technology delivery.
  • Prepare and deliver transparent, decision-ready reporting for governance forums, including Steering Committees and OCIO leadership.
  • Provide insights enabling leadership to evaluate risk exposure alongside investment, delivery progress, and business outcomes.
  • Highlight trade-offs, emerging risks, and areas requiring leadership attention or decisions.
  • Track key risk indicators, control effectiveness, and remediation progress.
  • Identify opportunities to streamline and improve GRC processes, tooling, and operating model effectiveness.
  • Contribute to the evolution of OCIO governance, risk, and control frameworks.

About the company

B

Brown & Brown Insurance

View

Brown & Brown provides risk management and insurance solutions to businesses and individuals through its Retail and Specialty Distribution segments. The company works by acting as an intermediary to identify specific risks and connect customers with tailored insurance policies that protect their assets. Unlike many competitors, it combines the scale of a large global brokerage with a decentralized culture that emphasizes local community involvement and a team-based approach to service. Its goal is to provide superior risk protection and long-term security for customers by consistently prioritizing their best interests.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Leeds, United Kingdom

Founded

1914

Get referred to Brown & Brown Insurance

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 30.4%; adjusted EBITDA hit $598 million.
  • Management expects $30 million-$40 million in Accession synergies during 2026.
  • Second-half organic growth guidance stays positive: Retail 1.5%-2.5%, Specialty Distribution 2%-4%.

What critics are saying

  • Organic revenue fell 0.7% in Q2 2026, exposing acquisition dependence.
  • Interest expense doubled to $100 million after Accession debt, squeezing margins and buybacks.
  • Private-equity-backed brokers keep poaching producers; one bad retention cycle can break organic growth.

What makes Brown & Brown Insurance unique

  • Accession added 2026 scale, lifting second-quarter revenue 30.4% to $1.68 billion.
  • Anthropic, McKinsey, and Accenture embed AI across 23,000 employees, widening operating leverage.
  • Brown & Brown spans 44 states and 14 countries, reducing dependence on any one market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Student Loan Assistance

Tuition Reimbursement

Mental Health Support

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 14th, 2026
Brown & Brown stock trades at 15.04X P/E, below industry average of 16.51X

Brown & Brown shares are trading at a discount to the insurance brokerage industry, with a forward price-to-earnings ratio of 15.04X versus the industry average of 16.51X. The company has a market capitalisation of $23.96 billion. The stock has gained 27.4% over the past three months, outperforming the industry's 22.4% growth. Analysts' average price target of $76.44 suggests a potential 7.6% upside from recent levels. The Zacks Consensus Estimate projects 2026 earnings per share to increase 5.6% year-over-year, with revenues reaching $7.04 billion, up 19.2%. Growth is supported by increasing new business, strong client retention, and strategic acquisitions. The company's recent Accession acquisition contributed approximately $410 million to second-quarter 2026 revenues, with expected synergies of $30-$40 million in 2026.

Yahoo Finance
Aug 13th, 2026
Brown & Brown tops insurance brokers' revenue growth but misses Q2 estimates by 2.5%

Five insurance brokers stocks reported largely satisfactory Q2 earnings, with revenues beating analyst consensus estimates by 0.8% overall. Share prices have held steady, rising 2.1% on average since results were released. Brown & Brown reported revenues of $1.68 billion, up 30.4% year on year. However, this figure fell short of analyst expectations by 2.5%. Despite scoring the fastest revenue growth amongst peers, it had the weakest performance against analyst estimates. The stock has risen 2.7% since reporting and currently trades at $71.60. Ryan Specialty delivered the strongest Q2 performance, reporting revenues of $916.6 million, up 7.2% year on year and outperforming analyst expectations by 5.3%. The insurance brokerage industry benefits from rising risk complexity and regulatory scrutiny, though faces challenges from labour intensity and wage inflation.

Yahoo Finance
Aug 3rd, 2026
Brown & Brown Q2 revenue misses estimates at $1.68B despite 30% growth

Brown & Brown reported second quarter 2026 results that missed revenue expectations but showed strong year-on-year growth. Revenue rose 30.4% to $1.68 billion, below the $1.72 billion analyst estimate. Management attributed performance to strong contingent commissions, effective acquisition integration, and improved sales processes. CEO J. Powell Brown said the company's enhanced sales model is building momentum with aligned teams generating new business wins. Operating margin declined year-over-year to 22.9% from 24.2%, though the company made progress controlling expenses. Adjusted EBITDA of $611 million beat analyst estimates of $603.1 million. During the earnings call, analysts questioned MGA competition impacts, European expansion plans, and technology investment costs. Management stressed disciplined underwriting and confirmed synergy targets remain unchanged.

Yahoo Finance
Aug 1st, 2026
Brown & Brown reports Q2 revenue of $1.68B but trades 6.9% below fair value target of $75.63

Brown & Brown reported Q2 2026 results with revenue of $1.676 billion and net income of $288 million. The insurance broker's shares closed at $70.40, posting a 22.16% gain over 90 days but down 9.30% year-to-date and 23.00% over one year. Valuation models suggest a fair value of $75.63, indicating the stock is 6.9% undervalued. The company's diversified portfolio across geographies and business lines supports earnings stability. However, the price-to-earnings ratio of 19.8x exceeds both the US insurance industry average of 12.1x and the stock's fair ratio of 12.5x. Risks include rising pharmacy costs in benefits and potential Florida legislative changes that could pressure margins.

Yahoo Finance
Jul 29th, 2026
Brown & Brown shares jump 5% on 30% revenue growth despite slight miss

Brown & Brown shares jumped 5% after reporting second-quarter results. The insurance brokerage firm's revenue grew 30.4% year-over-year to $1.68 billion, slightly below analyst estimates of $1.72 billion. Adjusted earnings per share came in at $1.07, exactly meeting Wall Street expectations. The positive market reaction suggests investors focused on strong top-line growth and profit targets rather than the minor revenue miss. The shares are down 5.9% year-to-date and trading at $73.05, which is 28.8% below their 52-week high of $102.58 from July 2025. Last month, Morgan Stanley downgraded the stock to "Underweight", citing concerns about organic growth reset and a softer pricing cycle.